Article ID: 08851bfc003a2a996e56d37d29e049810daa2944fbbbf09af7f58ec96a2cbf6b
Source ID: secondary:businessinsurance.com
Published At: -
Extraction Method: bs4_heuristic
URL: https://www.businessinsurance.com/us-supreme-court-scales-back-roundup-cancer-lawsuits/
Body Text
US Supreme Court scales back Roundup cancer lawsuits - Business Insurance Skip to content Register for free Search Search Log In Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2025 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Subscribe Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2025 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Subscribe Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2025 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Subscribe Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2025 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Subscribe Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers US Supreme Court scales back Roundup cancer lawsuits Claims Disputes , General liability , Risk Management Germany Jun 25, 2026 (Reuters) – The U.S. Supreme Court reined in thousands of lawsuits pursued in state courts accusing Bayer of failing to warn users that the active ingredient in its Roundup weedkiller causes cancer, handing a major legal victory on Thursday to the German company. The justices in a 7-2 decision overturned a jury verdict in Missouri awarding $1.25 million to a man named John Durnell who said he was diagnosed with non-Hodgkin lymphoma after years of exposure to glyphosate in Roundup. The Supreme Court agreed with Bayer that a U.S. law that governs pesticides precludes failure-to-warn claims that are brought under state law from moving forward in court. Bayer shares jumped nearly 18% following the ruling. President Donald Trump’s administration backed Bayer in the case. Conservative Justice Brett Kavanaugh, who authored the ruling, said the U.S. Environmental Protection Agency, or EPA, has concluded glyphosate does not cause cancer and has not required a cancer warning on Roundup. The law preempts Mr. Durnell’s claim because it “would require Monsanto to add a cancer warning to Roundup’s label even though federal law requires Monsanto to use the EPA-approved label without a cancer warning,” Justice Kavanaugh wrote. Liberal Justice Ketanji Brown Jackson, in a dissent joined by conservative Justice Neil Gorsuch, said that Mr. Durnell’s claim would impose equivalent labeling requirements on Monsanto that the federal law requires and so should not be preempted. Justice Jackson called the ruling “remarkable and regrettable, for it unjustifiably closes the courthouse doors to state tort plaintiffs like Durnell.” Bayer acquired Roundup as part of its $63 billion purchase of agrochemical company Monsanto in 2018. More than 100,000 plaintiffs have filed cases in U.S. state and federal courts alleging a cancer link, and the German drugmaking and crop science company had said that the lawsuits could threaten its ability to supply the herbicide to farmers. The torrent of litigation already prompted Bayer to remove glyphosate from its consumer version of Roundup. Bayer said before the Supreme Court ruled that a decision in its favor could largely end the Roundup litigation. “The U.S. Supreme Court decision is good for science, farmers, and industries that depend on regulatory clarity for innovation. It should help significantly contain the Roundup litigation after nearly a decade of legal battles. The ruling should result in the dismissal of current warning-based claims and bar future failure-to-warn claims,” company spokesperson Tino Andresen said in a statement. The company emphasized throughout the litigation that the EPA repeatedly found that glyphosate does not cause cancer and approved its product labels without a warning. Facing billions of dollars in potential liability, Bayer announced in February a proposed $7.25 billion settlement to resolve tens of thousands of current and future lawsuits. The settlement would not affect claims that stem from pending appeals or that fall outside the deal, according to the company. Those amount to nearly $1 billion, it said. Environmental activists and others criticized the court’s ruling on Thursday. “Once again, the Supreme Court has sided with big business over people and the environment. Today’s ruling is a disaster for public health,” said Tarah Heinzen, legal director at the advocacy group Food and Water Watch. “The harm from this decision will perpetuate our cancer, infertility and general chronic disease epidemic for generations to come,” said Kelly Ryerson, co-executive director of advocacy group American Regeneration and a Make America Healthy Again activist who posts on social media under the moniker “The Glyphosate Girl.” The sprawling dispute centers on a U.S. law called the Federal Insecticide, Fungicide and Rodenticide Act, or FIFRA, that governs the sale and labeling of pesticides and bars states from imposing differing or additional requirements. The measure prohibits pesticides that are “misbranded” with labels that lack an adequate warning to protect health and the environment. Bayer has argued that Mr. Durnell’s claims are preempted by this law. The EPA has repeatedly approved labels without such a cancer warning, demonstrating that these products are not misbranded, the company said, adding that labels cannot be substantially changed without the agency’s approval. Mr. Durnell’s lawyers said that despite the EPA’s registration of Roundup, the label may still be challenged as misbranded. They also said Mr. Durnell’s claims are not preempted because Missouri state law that requires products to adequately warn of dangers imposes the same requirements as FIFRA’s prohibition on misbranding. Union Investment fund manager Markus Manns called Thursday’s ruling a significant milestone for Bayer, adding that a decade after the Monsanto acquisition, the company is “entering a new era.” “While future lawsuits are not entirely off the table, they will become considerably more difficult. A final breakthrough would come if the settlement is accepted by the plaintiffs and approved by the competent court in July. This would bring Bayer’s glyphosate litigation chapter to a definitive close, allowing management to fully refocus on operational and strategic matters,” Mr. Manns said. Mr. Durnell sued Monsanto in Missouri state court in 2019, claiming it failed to warn users of the dangers associated with Roundup and glyphosate. He was diagnosed with a rare and often aggressive form of non-Hodgkin lymphoma, a cancer that starts in the white blood cells, and attributed the disease to his exposure to Roundup starting in 1996. For about 20 years he was the “spray guy” for a neighborhood association in St. Louis, killing weeds at local parks without protective equipment, according to court papers. A jury sided with Mr. Durnell in 2023, and in 2025 a state appeals court upheld that verdict. Some activists with the “Make America Healthy Again” movement that backs Trump’s Health Secretary Robert F. Kennedy Jr have criticized the Trump administration’s support for Bayer. Also backing Bayer in the case were a number of crop farming and agricultural industry groups. Several environmental, farm worker and public health groups backed Durnell. The Supreme Court heard arguments in the case in April. Related News Venezuela quakes cause widespread damage June 25, 2026 U.K. businesses face heatwave liability risk June 25, 2026 Allianz flags heightened geopolitical, operational marine risks June 25, 2026 GIC Re pivots away from overseas cat risk June 25, 2026 Double storm threat looms over Japan June 25, 2026 Gothaer secures $114M flood cat bond June 25, 2026 Apartment complex claims dent Hong Kong underwriting profit June 25, 2026 Airbus A380 cracks trigger urgent inspections June 25, 2026 EU’s probe into Meta’s ‘addictive design’ intensifies June 25, 2026 Facebook-f X-twitter Linkedin-in Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing. Never miss important news: Become a Business Insurance Online subscriber today Subscribe Now Information About Us Contact Advertise Privacy Policy Terms & Conditions Copyright 2026. BUSINESS INSURANCE HOLDINGS Member, Beacon International Group, Ltd.
Metadata (JSON)
{
"score": 24.0775
}